>
Dubai: cryptocurrency payments for government services thanks to Crypto.com
Shocking UFO files hidden in presidential library claim US made successful contact with an alien...
Southern state residents 'desperate to escape' but homes won't sell as crash looms
Trump blasts hysteria over Qatar's $400M gift: 'We're the USA'
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
One man, 856 venom hits, and the path to a universal snakebite cure
Dr. McCullough reveals cancer-fighting drug Big Pharma hopes you never hear about…
EXCLUSIVE: Raytheon Whistleblower Who Exposed The Neutrino Earthquake Weapon In Antarctica...
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision
Dark Matter: An 86-lb, 800-hp EV motor by Koenigsegg
Spacetop puts a massive multi-window workspace in front of your eyes
The technique could be a boon for regenerative medicine to treat neurological disorders.
Inflammation is the body's natural response to injury and damage, swelling up to allow better blood flow to the area. It also acts like a "fire alarm" to attract the attention of the immune system to help the healing process, and stem cells are some of the most important responders.
In theory, inflammation could be used to lure these regenerative stem cells to injuries, but of course there are risks. Chronic inflammation underlies conditions like arthritis, multiple sclerosis and Crohn's disease, and has even been linked to cardiovascular diseases, Alzheimer's and depression.
So for the new study, the researchers investigated ways to summon stem cells using inflammation signals without creating further inflammation. The team modified an inflammatory molecule called CXCL12, which had previously been identified as a stem cell attractor. They found that it contains two "pockets" – one that binds to stem cells and one for inflammatory signaling – so they developed a drug that maximizes the binding but minimizes the signaling.
The end result is a drug they call SDV1a, which is designed to be injected almost anywhere in the body to lure stem cells there to begin healing an injury, without causing inflammation.